QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)
QQQ   414.08 (-2.20%)
AAPL   165.02 (-1.21%)
MSFT   399.11 (-1.28%)
META   481.95 (-3.96%)
GOOGL   154.23 (-1.14%)
AMZN   174.65 (-2.55%)
TSLA   147.13 (-1.87%)
NVDA   763.66 (-9.81%)
AMD   146.71 (-5.40%)
NIO   3.80 (-5.00%)
BABA   69.06 (+0.26%)
T   16.50 (+1.04%)
F   12.14 (+0.66%)
MU   106.90 (-4.49%)
GE   148.08 (-3.18%)
CGC   7.97 (+1.79%)
DIS   112.58 (+0.13%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   62.26 (+0.26%)
XOM   119.97 (+1.22%)

Silence Therapeutics (SLN) News Today

GBX 535
-5.00 (-0.93%)
(As of 11/29/2021)
SourceHeadline
nasdaq.com logoSilence Therapeutics Plc American Depository Share (SLN)
nasdaq.com - April 13 at 11:50 AM
MarketBeat logoSilence Therapeutics (LON:SLN) Stock Price Crosses Below 200-Day Moving Average of $535.00
americanbankingnews.com - April 12 at 3:06 AM
msn.com logo‘Quiet on Set’ to Launch Fifth Episode ‘Breaking the Silence’ With New Drake Bell Interview and More
msn.com - March 28 at 2:57 PM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
finanznachrichten.de - March 13 at 9:23 AM
msn.com logoSilence Therapeutics gains on mid-stage win for lead asset
msn.com - March 13 at 9:23 AM
msn.com logoSilence Therapeutics Jumps on Clinical Trials
msn.com - February 23 at 1:45 PM
finance.yahoo.com logoBroker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher
finance.yahoo.com - February 7 at 9:08 AM
realmoney.thestreet.com logoIs Silence Golden for This Small-Cap Biotech Stock?
realmoney.thestreet.com - January 31 at 12:52 PM
finance.yahoo.com logoSilence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
finance.yahoo.com - January 31 at 7:52 AM
msn.com logoAll You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy
msn.com - January 11 at 1:26 PM
finance.yahoo.com logoSilence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's Why
finance.yahoo.com - January 5 at 1:20 PM
finance.yahoo.com logoThis Silence Therapeutics Insider Increased Their Holding In The Last Year
finance.yahoo.com - December 24 at 8:11 AM
finance.yahoo.com logoHere's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep going
finance.yahoo.com - December 15 at 1:02 PM
finance.yahoo.com logoDoes Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?
finance.yahoo.com - December 6 at 1:25 PM
morningstar.com logoSilence Therapeutics PLC ADR SLN
morningstar.com - November 21 at 6:07 PM
markets.businessinsider.com logoSilence Therapeutics: Bullish Outlook on SLN360 and Future Potential Despite Thalassemia Program Discontinuation
markets.businessinsider.com - November 16 at 5:52 PM
markets.businessinsider.com logoIs This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease Candidate
markets.businessinsider.com - November 1 at 8:22 PM
marketwatch.com logoSilence Therapeutics ADRs Rise 22% After Positive Trial Results
marketwatch.com - November 1 at 3:22 PM
msn.com logoEuropean Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
msn.com - October 27 at 12:15 PM
msn.com logoAT&T Unveils “Sound of Silence” Ad to Tout 5G Football Helmet Partnership
msn.com - October 14 at 12:12 AM
finance.yahoo.com logoSilence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
finance.yahoo.com - September 26 at 8:27 AM
markets.businessinsider.com logoWhere Silence Therapeutics Stands With Analysts
markets.businessinsider.com - August 17 at 12:14 PM
fool.com logoSilence Therapeutics Plc (NASDAQ: SLN)
fool.com - June 25 at 3:53 PM
markets.businessinsider.com logoThe Latest Analyst Ratings for Silence Therapeutics
markets.businessinsider.com - May 11 at 3:28 PM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
finanznachrichten.de - March 28 at 10:02 AM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics to Buyback siRNA Complement Assets
finanznachrichten.de - March 28 at 10:02 AM
finance.yahoo.com logoSilence Therapeutics to Buyback siRNA Complement Assets
finance.yahoo.com - March 28 at 10:02 AM
finance.yahoo.com logoSilence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
finance.yahoo.com - March 28 at 10:02 AM
yahoo.com logoRaquel Leviss breaks her silence, Tom Sandoval finally apologizes to Ariana Madix: Here's the 'Scandoval' latest
yahoo.com - March 10 at 11:32 PM
finance.yahoo.com logoSilence Therapeutics to Present at SVB Securities Global Biopharma Conference
finance.yahoo.com - February 8 at 8:04 AM
wsj.com logoSilence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations Officer
wsj.com - February 6 at 9:52 AM
finance.yahoo.com logoSilence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
finance.yahoo.com - January 12 at 6:10 PM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics Reports Third Quarter 2022 Results
finanznachrichten.de - November 10 at 5:46 PM
finance.yahoo.com logoSilence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with Thalassemia
finance.yahoo.com - September 29 at 7:55 AM
finance.yahoo.com logoSilence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference
finance.yahoo.com - September 27 at 8:55 AM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics Announces Pricing of Underwritten Offering
finanznachrichten.de - August 13 at 10:20 PM
wsj.com logoSilence Therapeutics PLC ADR
wsj.com - July 15 at 11:55 PM
benzinga.com logoSilence Therapeutics (NASDAQ:SLN), Short Interest Report
benzinga.com - June 17 at 4:10 PM
finance.yahoo.com logoSilence Therapeutics to Participate in Fireside Chat at H.C. Wainwright Global Investment Conference
finance.yahoo.com - May 18 at 11:23 AM
seekingalpha.com logoSilence Therapeutics to get $3M from Mallinckrodt as trial application for SLN501 filed
seekingalpha.com - March 23 at 9:43 AM
finance.yahoo.com logoSilence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501
finance.yahoo.com - March 23 at 9:43 AM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics Reports Fourth Quarter and Full Year 2021 Results
finanznachrichten.de - March 17 at 10:05 AM
benzinga.com logoSilence Therapeutics Reports FY21 Sales £12.4M Up From £5.5M YoY
benzinga.com - March 17 at 10:05 AM
finance.yahoo.com logoSilence Therapeutics Reports Fourth Quarter and Full Year 2021 Results
finance.yahoo.com - March 17 at 10:05 AM
seekingalpha.com logoSilence Therapeutics granted Orphan Drug status for rare blood disorder candidate
seekingalpha.com - February 26 at 7:17 PM
finance.yahoo.com logoSilence Therapeutics Posts First Human Data For Cardiovascular Candidate
finance.yahoo.com - February 9 at 8:31 PM
finance.yahoo.com logoSilence Therapeutics’ Head of Molecular Design Dr. Marie Wikström Lindholm Appointed to Oligonucleotide Therapeutics Society Board of Directors
finance.yahoo.com - January 18 at 9:27 AM
finance.yahoo.com logoSilence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conference
finance.yahoo.com - January 5 at 8:13 AM
finanznachrichten.de logoSilence Therapeutics plc: Silence Therapeutics Begins Exclusive Nasdaq Trading
finanznachrichten.de - December 16 at 2:33 AM
finance.yahoo.com logoSilence Therapeutics Begins Exclusive Nasdaq Trading
finance.yahoo.com - November 30 at 7:49 AM
Get Silence Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

SLN Media Mentions By Week

SLN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLN
News Sentiment

0.30

0.52

Average
Medical
News Sentiment

SLN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLN Articles
This Week

1

0

SLN Articles
Average Week

Get Silence Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:SLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners